Vifor Pharma aims to be a leader in iron deficiency, nephrology and cardio-renal therapies. We strive to help patients with severe and chronic disease lead better, healthier lives.

When scheduling a meeting with Vifor Medical Affairs booth staff member, please note that these contacts are ONLY for general disease state information by a US healthcare professional, and not for reporting information about any medication side effects. To report adverse reactions, contact Vifor Inc. at 1-844-735-9772.

For more information on hyperkalemia in patients with heart failure, please see the resources below.

Click here to request additional information on hyperkalemia

Click here to connect to educational programming on hyperkalemia in heart failure

Question 1: What is hyperkalemia and why does it occur in patients with heart failure?

Question 2: How common is hyperkalemia in patients with heart failure?

Question 3: What are the consequences of hyperkalemia?

Question 4: What are considerations for patients with heart failure?

Question 5: What do the ACC/AHA/HFSA guidelines say about RAASi and potassium?

Question 6: Is there practical guidance or expert opinion on the management of hyperkalemia?